All News #Library
Biotech
Cadrenal Therapeutics Acquires Phase 2 12-LOX Inhibitor VLX-1005
12 Dec 2025 //
GLOBENEWSWIRE
Veralox Expands Pipeline With Option To Acquire Nudge Therapeutics
09 Jan 2025 //
PR NEWSWIRE

Market Place
Sourcing Support